Skip to main content

Advertisement

SpringerLink
Log in

Increasing fasting glucose and fasting insulin associated with elevated bone mineral density—evidence from cross-sectional and MR studies

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

We performed a cross-sectional study using the National Health Examination and Nutrition Survey (NHANES) data and a Mendelian randomisation (MR) study using the GWAS summary statistics from European populations. The T2D-related indices (fasting plasma glucose (FPG), fasting insulin (FI), and insulin resistance (IR)) were found to associate with elevated bone mineral density (BMD).

Introduction

The known associations amongst FPG, FI, IR, and BMD remain inconsistent. This study aims to explore the abovementioned associations by using cross-sectional and MR designs.

Methods

Data from adults aged ≥ 20 years (n = 7170) in four rounds of the U.S. NHANES (2005–2010 and 2013–2014) were analysed in this cross-sectional study. Multiple linear and logistic regression models were used for statistical analyses. A two-sample MR study was performed using the genome-wide association study summary statistics obtained from the Meta-analyses of Glucose and Insulin-related traits Consortium (n = 108,557) and Genetic Factors for Osteoporosis Consortium (n = 32,735) to examine the causality of the FI–BMD association.

Results

Multiple linear regression revealed that FPG was positively associated with the BMDs at the hip, femur neck, and 1st lumbar spine (L1). Multiple logistic regressions revealed that FPG levels were associated with elevated BMDs at the hip and L1, and FI and IR levels were associated with elevated BMD at the hip. Patients with type 2 diabetes had higher hip BMD than those without diabetes. In the MR study, the lumbar spine BMD increased by 0.49 g/cm2 (95% confidence interval: 0.01, 0.97) in response to per unit increase in log-transformed FI.

Conclusion

Findings from our cross-sectional and MR studies revealed the associations between the studied diabetic indices and BMD measurements in the US and European adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. (2000) Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Statement 17:1–45

  2. Sambrook PN (1996) Osteoporosis. Med J Aust 165:332–336

    Article  CAS  PubMed  Google Scholar 

  3. Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194:S3–S11

    Article  CAS  PubMed  Google Scholar 

  4. Greenblatt MB, Tsai JN, Wein MN (2017) Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clin Chem 63:464–474

    Article  CAS  PubMed  Google Scholar 

  5. Patrocinio-Silva TL, de Souza AM, Goulart RL, Pegorari CF, Oliveira JR, Fernandes K, Magri A, Pereira RM, Araki DR, Nagaoka MR, Parizotto NA, Renno AC (2014) The effects of low-level laser irradiation on bone tissue in diabetic rats. Lasers Med Sci 29:1357–1364

    PubMed  Google Scholar 

  6. Sealand R, Razavi C, Adler RA (2013) Diabetes mellitus and osteoporosis. Curr Diab Rep 13:411–418

    Article  CAS  PubMed  Google Scholar 

  7. Lipscombe LL, Jamal SA, Booth GL, Hawker GA (2007) The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care 30:835–841

    Article  PubMed  Google Scholar 

  8. Ma L, Oei L, Jiang L, Estrada K, Chen H, Wang Z, Yu Q, Zillikens MC, Gao X, Rivadeneira F (2012) Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol 27:319–332

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int 18:427–444

    Article  CAS  PubMed  Google Scholar 

  10. Saller A, Maggi S, Romanato G, Tonin P, Crepaldi G (2008) Diabetes and osteoporosis. Aging Clin Exp Res 20:280–289

    Article  PubMed  Google Scholar 

  11. Shanbhogue VV, Finkelstein JS, Bouxsein ML, Yu EW (2016) Association between insulin resistance and bone structure in nondiabetic postmenopausal women. J Clin Endocrinol Metab 101:3114–3122

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Shin D, Kim S, Kim KH, Lee K, Park SM (2014) Association between insulin resistance and bone mass in men. J Clin Endocrinol Metab 99:988–995

    Article  CAS  PubMed  Google Scholar 

  13. Yang J, Hong N, Shim JS, Rhee Y, Kim HC (2018) Association of insulin resistance with lower bone volume and strength index of the proximal femur in nondiabetic postmenopausal women. J Bone Metab 25:123–132

    Article  PubMed  PubMed Central  Google Scholar 

  14. Ruppert K, Cauley J, Lian Y, Zgibor JC, Derby C, Solomon DH (2018) The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study. Osteoporos Int 29:347–354

    Article  CAS  PubMed  Google Scholar 

  15. Yan W, Li X (2013) Impact of diabetes and its treatments on skeletal diseases. Front Med 7:81–90

    Article  PubMed  Google Scholar 

  16. Thrailkill KM, Lumpkin CJ, Bunn RC, Kemp SF, Fowlkes JL (2005) Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 289:E735–E745

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ghodsi M, Larijani B, Keshtkar AA, Nasli-Esfahani E, Alatab S, Mohajeri-Tehrani MR (2016) Mechanisms involved in altered bone metabolism in diabetes: a narrative review. J Diabetes Metab Disord 15:52

    Article  PubMed  PubMed Central  Google Scholar 

  18. Adami S (2009) Bone health in diabetes: considerations for clinical management. Curr Med Res Opin 25:1057–1072

    Article  PubMed  Google Scholar 

  19. Arikan S, Tuzcu A, Bahceci M, Ozmen S, Gokalp D (2012) Insulin resistance in type 2 diabetes mellitus may be related to bone mineral density. J Clin Densitom 15:186–190

    Article  PubMed  Google Scholar 

  20. Faulhaber GA, Premaor MO, Moser FH, Silla LM, Furlanetto TW (2009) Low bone mineral density is associated with insulin resistance in bone marrow transplant subjects. Bone Marrow Transplant 43:953–957

    Article  CAS  PubMed  Google Scholar 

  21. Smith GD, Ebrahim S (2003) ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32:1–22

    Article  PubMed  Google Scholar 

  22. Emdin CA, Khera AV, Kathiresan S (2017) Mendelian randomization. JAMA 318:1925–1926

    Article  PubMed  Google Scholar 

  23. Ahmad OS, Leong A, Miller JA, Morris JA, Forgetta V, Mujammami M, Richards JB (2017) A Mendelian randomization study of the effect of type-2 diabetes and glycemic traits on bone mineral density. J Bone Miner Res 32:1072–1081

    Article  CAS  PubMed  Google Scholar 

  24. Eze IC, Hemkens LG, Bucher HC, Hoffmann B, Schindler C, Kunzli N, Schikowski T, Probst-Hensch NM (2015) Association between ambient air pollution and diabetes mellitus in Europe and North America: systematic review and meta-analysis. Environ Health Perspect 123:381–389

    Article  PubMed  PubMed Central  Google Scholar 

  25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419

    Article  CAS  Google Scholar 

  26. Tenne M, McGuigan F, Besjakov J, Gerdhem P, Akesson K (2013) Degenerative changes at the lumbar spine--implications for bone mineral density measurement in elderly women. Osteoporos Int 24:1419–1428

    Article  CAS  PubMed  Google Scholar 

  27. Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J, Magi R, Strawbridge RJ, Rehnberg E, Gustafsson S, Kanoni S, Rasmussen-Torvik LJ, Yengo L, Lecoeur C, Shungin D, Sanna S, Sidore C, Johnson PC, Jukema JW, Johnson T, Mahajan A, Verweij N, Thorleifsson G, Hottenga JJ, Shah S, Smith AV, Sennblad B, Gieger C, Salo P, Perola M, Timpson NJ, Evans DM, Pourcain BS, Wu Y, Andrews JS, Hui J, Bielak LF, Zhao W, Horikoshi M, Navarro P, Isaacs A, O'Connell JR, Stirrups K, Vitart V, Hayward C, Esko T, Mihailov E, Fraser RM, Fall T, Voight BF, Raychaudhuri S, Chen H, Lindgren CM, Morris AP, Rayner NW, Robertson N, Rybin D, Liu CT, Beckmann JS, Willems SM, Chines PS, Jackson AU, Kang HM, Stringham HM, Song K, Tanaka T, Peden JF, Goel A, Hicks AA, An P, Muller-Nurasyid M, Franco-Cereceda A, Folkersen L, Marullo L, Jansen H, Oldehinkel AJ, Bruinenberg M, Pankow JS, North KE, Forouhi NG, Loos RJ, Edkins S, Varga TV, Hallmans G, Oksa H, Antonella M, Nagaraja R, Trompet S, Ford I, Bakker SJ, Kong A, Kumari M, Gigante B, Herder C, Munroe PB, Caulfield M, Antti J, Mangino M, Small K, Miljkovic I, Liu Y, Atalay M, Kiess W, James AL, Rivadeneira F, Uitterlinden AG, Palmer CN, Doney AS, Willemsen G, Smit JH, Campbell S, Polasek O, Bonnycastle LL, Hercberg S, Dimitriou M, Bolton JL, Fowkes GR, Kovacs P, Lindstrom J, Zemunik T, Bandinelli S, Wild SH, Basart HV, Rathmann W, Grallert H, Maerz W, Kleber ME, Boehm BO, Peters A, Pramstaller PP, Province MA, Borecki IB, Hastie ND, Rudan I, Campbell H, Watkins H, Farrall M, Stumvoll M, Ferrucci L, Waterworth DM, Bergman RN, Collins FS, Tuomilehto J, Watanabe RM, de Geus EJ, Penninx BW, Hofman A, Oostra BA, Psaty BM, Vollenweider P, Wilson JF, Wright AF, Hovingh GK, Metspalu A, Uusitupa M, Magnusson PK, Kyvik KO, Kaprio J, Price JF, Dedoussis GV, Deloukas P, Meneton P, Lind L, Boehnke M, Shuldiner AR, van Duijn CM, Morris AD, Toenjes A, Peyser PA, Beilby JP, Korner A, Kuusisto J, Laakso M, Bornstein SR, Schwarz PE, Lakka TA, Rauramaa R, Adair LS, Smith GD, Spector TD, Illig T, de Faire U, Hamsten A, Gudnason V, Kivimaki M, Hingorani A, Keinanen-Kiukaanniemi SM, Saaristo TE, Boomsma DI, Stefansson K, van der Harst P, Dupuis J, Pedersen NL, Sattar N, Harris TB, Cucca F, Ripatti S, Salomaa V, Mohlke KL, Balkau B, Froguel P, Pouta A, Jarvelin MR, Wareham NJ, Bouatia-Naji N, McCarthy MI, Franks PW, Meigs JB, Teslovich TM, Florez JC, Langenberg C, Ingelsson E, Prokopenko I, Barroso I (2012) Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 44:991–1005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Zheng HF, Forgetta V, Hsu YH, Estrada K, Rosello-Diez A, Leo PJ, Dahia CL, Park-Min KH, Tobias JH, Kooperberg C, Kleinman A, Styrkarsdottir U, Liu CT, Uggla C, Evans DS, Nielson CM, Walter K, Pettersson-Kymmer U, McCarthy S, Eriksson J, Kwan T, Jhamai M, Trajanoska K, Memari Y, Min J, Huang J, Danecek P, Wilmot B, Li R, Chou WC, Mokry LE, Moayyeri A, Claussnitzer M, Cheng CH, Cheung W, Medina-Gomez C, Ge B, Chen SH, Choi K, Oei L, Fraser J, Kraaij R, Hibbs MA, Gregson CL, Paquette D, Hofman A, Wibom C, Tranah GJ, Marshall M, Gardiner BB, Cremin K, Auer P, Hsu L, Ring S, Tung JY, Thorleifsson G, Enneman AW, van Schoor NM, de Groot LC, van der Velde N, Melin B, Kemp JP, Christiansen C, Sayers A, Zhou Y, Calderari S, van Rooij J, Carlson C, Peters U, Berlivet S, Dostie J, Uitterlinden AG, Williams SR, Farber C, Grinberg D, LaCroix AZ, Haessler J, Chasman DI, Giulianini F, Rose LM, Ridker PM, Eisman JA, Nguyen TV, Center JR, Nogues X, Garcia-Giralt N, Launer LL, Gudnason V, Mellstrom D, Vandenput L, Amin N, van Duijn CM, Karlsson MK, Ljunggren O, Svensson O, Hallmans G, Rousseau F, Giroux S, Bussiere J, Arp PP, Koromani F, Prince RL, Lewis JR, Langdahl BL, Hermann AP, Jensen JE, Kaptoge S, Khaw KT, Reeve J, Formosa MM, Xuereb-Anastasi A, Akesson K, McGuigan FE, Garg G, Olmos JM, Zarrabeitia MT, Riancho JA, Ralston SH, Alonso N, Jiang X, Goltzman D, Pastinen T, Grundberg E, Gauguier D, Orwoll ES, Karasik D, Davey-Smith G, Smith AV, Siggeirsdottir K, Harris TB, Zillikens MC, van Meurs JB, Thorsteinsdottir U, Maurano MT, Timpson NJ, Soranzo N, Durbin R, Wilson SG, Ntzani EE, Brown MA, Stefansson K, Hinds DA, Spector T, Cupples LA, Ohlsson C, Greenwood CM, Jackson RD, Rowe DW, Loomis CA, Evans DM, Ackert-Bicknell CL, Joyner AL, Duncan EL, Kiel DP, Rivadeneira F, Richards JB (2015) Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture. Nature 526:112–117

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Didelez V, Sheehan N (2007) Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 16:309–330

    Article  PubMed  Google Scholar 

  30. Li KH, Liu YT, Yang YW, Lin YL, Hung ML, Lin IC (2018) A positive correlation between blood glucose level and bone mineral density in Taiwan. Arch Osteoporos 13:78

    Article  PubMed  Google Scholar 

  31. Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, Johnson KC, Margolis KL (2006) Risk of fracture in women with type 2 diabetes: the Women’s Health Initiative Observational Study. J Clin Endocrinol Metab 91:3404–3410

    Article  CAS  PubMed  Google Scholar 

  32. de Liefde II, van der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA (2005) Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 16:1713–1720

    Article  PubMed  Google Scholar 

  33. Hu Z, Ma C, Liang Y, Zou S, Liu X (2019) Osteoclasts in bone regeneration under type 2 diabetes mellitus. Acta Biomater 84:402–413

    Article  CAS  PubMed  Google Scholar 

  34. Wasnich RD, Benfante RJ, Yano K, Heilbrun L, Vogel JM (1983) Thiazide effect on the mineral content of bone. N Engl J Med 309:344–347

    Article  CAS  PubMed  Google Scholar 

  35. Pasco JA, Kotowicz MA, Henry MJ, Sanders KM, Nicholson GC (2002) Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study. Arch Intern Med 162:537–540

    Article  CAS  PubMed  Google Scholar 

  36. Leslie WD, Rubin MR, Schwartz AV, Kanis JA (2012) Type 2 diabetes and bone. J Bone Miner Res 27:2231–2237

    Article  PubMed  Google Scholar 

  37. Sassi F, Buondonno I, Luppi C, Spertino E, Stratta E, Di Stefano M, Ravazzoli M, Isaia G, Trento M, Passera P, Porta M, Isaia GC, D'Amelio P (2018) Type 2 diabetes affects bone cells precursors and bone turnover. BMC Endocr Disord 18:55

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kasim NB, Huri HZ, Vethakkan SR, Ibrahim L, Abdullah BM (2016) Genetic polymorphisms associated with overweight and obesity in uncontrolled Type 2 diabetes mellitus. Biomark Med 10:403–415

    Article  CAS  PubMed  Google Scholar 

  39. Kaliora AC, Kalafati IP, Gioxari A, Diolintzi A, Kokkinos A, Dedoussis GV (2018) A modified response of NAFLD patients with non-significant fibrosis in nutritional counseling according to GCKR rs1260326. Eur J Nutr 57:2227–2235

    Article  CAS  PubMed  Google Scholar 

  40. Zhang Y, Gan W, Tian C, Li H, Lin X, Chen Y (2013) Association of PPP1R3B polymorphisms with blood lipid and C-reactive protein levels in a Chinese population (PPP1R3B C ). J Diabetes 5:275–281

    Article  CAS  PubMed  Google Scholar 

  41. Lundback V, Kulyte A, Strawbridge RJ, Ryden M, Arner P, Marcus C, Dahlman I (2018) FAM13A and POM121C are candidate genes for fasting insulin: functional follow-up analysis of a genome-wide association study. Diabetologia 61:1112–1123

    Article  PubMed  PubMed Central  Google Scholar 

  42. Klimentidis YC, Arora A (2016) Interaction of insulin resistance and related genetic variants with triglyceride-associated genetic variants. Circ Cardiovasc Genet 9:154–161

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Ishii S, Cauley JA, Crandall CJ, Srikanthan P, Greendale GA, Huang MH, Danielson ME, Karlamangla AS (2012) Diabetes and femoral neck strength: findings from the Hip Strength Across the Menopausal Transition Study. J Clin Endocrinol Metab 97:190–197

    Article  CAS  PubMed  Google Scholar 

  44. Conte C, Epstein S, Napoli N (2018) Insulin resistance and bone: a biological partnership. Acta Diabetol 55:305–314

    Article  CAS  PubMed  Google Scholar 

  45. Reaven GM (2011) Insulin resistance: the link between obesity and cardiovascular disease. Med Clin North Am 95:875–892

    Article  CAS  PubMed  Google Scholar 

  46. Thommesen L, Stunes AK, Monjo M, Grosvik K, Tamburstuen MV, Kjobli E, Lyngstadaas SP, Reseland JE, Syversen U (2006) Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem 99:824–834

    Article  CAS  PubMed  Google Scholar 

  47. Kasukawa Y, Miyakoshi N, Mohan S (2004) The anabolic effects of GH/IGF system on bone. Curr Pharm Des 10:2577–2592

    Article  CAS  PubMed  Google Scholar 

  48. Yakar S, Canalis E, Sun H, Mejia W, Kawashima Y, Nasser P, Courtland HW, Williams V, Bouxsein M, Rosen C, Jepsen KJ (2009) Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions. J Bone Miner Res 24:1481–1492

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Hong AR, Kim JH, Lee JH, Kim SW, Shin CS (2019) Metabolic characteristics of subjects with spine-femur bone mineral density discordances: the Korean National Health and Nutrition Examination Survey (KNHANES 2008-2011). J Bone Miner Metab 37:835–843

  50. Blank RD, Malone DG, Christian RC, Vallarta-Ast NL, Krueger DC, Drezner MK, Binkley NC, Hansen KE (2006) Patient variables impact lumbar spine dual energy X-ray absorptiometry precision. Osteoporos Int 17:768–774

    Article  CAS  PubMed  Google Scholar 

  51. Engin AB (2017) What is lipotoxicity? Adv Exp Med Biol 960:197–220

    Article  CAS  PubMed  Google Scholar 

  52. Napoli N, Conte C, Pedone C, Strotmeyer ES, Barbour KE, Black DM, Samelson EJ, Schwartz AV (2019) Effect of insulin resistance on BMD and fracture risk in older adults. J Clin Endocrinol Metab 104:3303–3310

    Article  PubMed  PubMed Central  Google Scholar 

  53. Srikanthan P, Crandall CJ, Miller-Martinez D, Seeman TE, Greendale GA, Binkley N, Karlamangla AS (2014) Insulin resistance and bone strength: findings from the study of midlife in the United States. J Bone Miner Res 29:796–803

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Costantini S, Conte C (2019) Bone health in diabetes and prediabetes. World J Diabetes 10:421–445

    Article  PubMed  PubMed Central  Google Scholar 

  55. Javed F, Yu W, Thornton J, Colt E (2009) Effect of fat on measurement of bone mineral density. Int J Body Compos Res 7:37–40

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Botolin S, McCabe LR (2006) Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99:411–424

    Article  CAS  PubMed  Google Scholar 

  57. Sheu Y, Amati F, Schwartz AV, Danielson ME, Li X, Boudreau R, Cauley JA (2017) Vertebral bone marrow fat, bone mineral density and diabetes: the Osteoporotic Fractures in Men (MrOS) study. Bone 97:299–305

    Article  PubMed  PubMed Central  Google Scholar 

  58. Richards JB, Zheng HF, Spector TD (2012) Genetics of osteoporosis from genome-wide association studies: advances and challenges. Nat Rev Genet 13:576–588

    Article  CAS  PubMed  Google Scholar 

  59. Tagi VM, Giannini C, Chiarelli F (2019) Insulin resistance in children. Front Endocrinol (Lausanne) 10:342

    Article  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by the Natural Science Foundation of Hubei Province (grant nos.: 2019CFB647 and 2019CFB709) and the Fundamental Research Funds for the Central Universities (grant no. 2019kfyXKJC003).

Author information

Authors and Affiliations

  1. MOE Key Laboratory of Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    H. Zhou, C. Li, W. Song, M. Wei, Y. Cui & Q. Wang

  2. Department of Rehabilitation Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Q. Huang

Authors
  1. H. Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Q. Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Q. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Q. Huang or Q. Wang.

Ethics declarations

Conflicts of interest

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 140 kb).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, H., Li, C., Song, W. et al. Increasing fasting glucose and fasting insulin associated with elevated bone mineral density—evidence from cross-sectional and MR studies. Osteoporos Int 32, 1153–1164 (2021). https://doi.org/10.1007/s00198-020-05762-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-020-05762-w

Keywords

Search

Navigation